Secondary analysis of a randomized, placebo-controlled study of 1,000+ participants indicated that FDA-authorized RelieVRx® yielded clinically meaningful pain intensity and pain…
Groundbreaking thinkALS™ Tool Empowers Providers to Identify and Refer Patients Quicker ARLINGTON, Va., Dec. 10, 2024 /PRNewswire/ -- It can take…
Collaboration Focuses on Streamlining VA Disability Claims, Expanding Veteran Support Services, and Enhancing Resources AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/…
Redefining Advocacy for the Injured and The Unsettling Truth About SettlingTORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- In an effort…
Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County MISSION VIEJO, CAPELLEN /…
Nes-Ziona, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…
The sNDA submission is based on positive results from Studies 501 and 502 demonstrating CAPLYTA’s robust antidepressant efficacy and favorable…
HO CHI MINH CITY, Vietnam, Nov. 29, 2024 /PRNewswire/ -- After several years of intensive investment in R&D, TMA Solutions launched…
Two top healthcare awards underline Brainomix's landmark achievements in 2024 and the validation of its software's impact on treatment ratesOXFORD,…
TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")…